Difficulty: Medium
Average Score: 81%
Practice
A 66-year-old man complains of nocturia (three to four times a night), hesitancy, and incomplete emptying of the bladder. Physical examination reveals an enlarged, nontender prostate, about 40 g in size without discrete nodules. Urinalysis reveals hematuria without leukocyte esterase. Upon further evaluation, the hematuria is attributed to his BPH. The patient declines surgical options at this time. Which of the following medications would be most appropriate?
Correct answer
B
Rationale
In this case, the most appropriate medication for the 66-year-old man with BPH who has declined surgical options is Doxazosin (option B). Doxazosin is an alpha-1 adrenergic blocker that helps relax the smooth muscle in the prostate and bladder neck, improving urinary symptoms associated with BPH such as hesitancy and incomplete emptying of the bladder. It does not shrink the prostate but helps alleviate symptoms.
Option A, Oxybutynin, is a medication used for overactive bladder and would not address the underlying issue of BPH in this patient. Option C, Finasteride, is a 5-alpha reductase inhibitor that can help shrink the prostate over time but may not provide immediate relief for bothersome symptoms like nocturia. Option D, Silodosin, is another alpha-1 adrenergic blocker like Doxazosin but may not be as commonly used or as well-established for BPH management in clinical practice.
In an educational context, understanding the rationale behind selecting appropriate medications for BPH is crucial for healthcare providers to provide optimal care for patients. It is important to consider both the mechanism of action of the medications and the specific symptoms and preferences of the individual patient when making treatment decisions in clinical practice.
Option A, Oxybutynin, is a medication used for overactive bladder and would not address the underlying issue of BPH in this patient. Option C, Finasteride, is a 5-alpha reductase inhibitor that can help shrink the prostate over time but may not provide immediate relief for bothersome symptoms like nocturia. Option D, Silodosin, is another alpha-1 adrenergic blocker like Doxazosin but may not be as commonly used or as well-established for BPH management in clinical practice.
In an educational context, understanding the rationale behind selecting appropriate medications for BPH is crucial for healthcare providers to provide optimal care for patients. It is important to consider both the mechanism of action of the medications and the specific symptoms and preferences of the individual patient when making treatment decisions in clinical practice.